A2 Bio’s new CEO aims to grow platform
James Robinson, the new CEO of Agoura Hills-based A2 Biotherapeutics, has several priorities he wants to tackle, not the least of which is to accelerate the company’s proprietary Tmod cell therapy platform. “First principle for us is to maximize the value of the platform that we’ve built,” Robinson, 54, told the Business Times on April Read More →
Street smarts: Workzones to host free talk on April 9
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Our view: Leaving behind a strong legacy of helping others
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Mikuna CEO brings protein from Andes to Whole Foods
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
EP Wealth snaps up Wacker Wealth in SLO
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Analysts believe Semtech is cornering IoT market
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Analysts remain all-in on Deckers stock as shares near $1K
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
